Does rectal indomethacin prevent post-ERCP pancreatitis in average-risk patients?

Gastrointest Endosc. 2017 Mar;85(3):687. doi: 10.1016/j.gie.2016.10.004.

Authors

Xing-Kang He¹, Lei-Min Sun¹

Affiliation

¹ Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University Medical School, Hangzhou, China; Institute of Gastroenterology, Zhejiang University, Hangzhou, China.

PMID: 28215778
DOI: 10.1016/j.gie.2016.10.004

No abstract available

Publication types

Letter
Comment

MeSH terms

Administration, Rectal
Anti-Inflammatory Agents, Non-Steroidal
Cholangiopancreatography, Endoscopic Retrograde
Humans
Indomethacin*
Pancreatitis*
Risk
Risk Factors

Substances

Anti-Inflammatory Agents, Non-Steroidal
Indomethacin